This is a Validated Antibody Database (VAD) review about human CD86, based on 172 published articles (read how Labome selects the articles), using CD86 antibody in all methods. It is aimed to help Labome visitors find the most suited CD86 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD86 synonym: B7-2; B7.2; B70; CD28LG2; LAB72

BioLegend
mouse monoclonal (BU63)
  • flow cytometry; human; 1:20; loading ...; fig 3b
BioLegend CD86 antibody (Biolegend, 374207) was used in flow cytometry on human samples at 1:20 (fig 3b). Bioengineered (2022) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...
BioLegend CD86 antibody (Biolegend, 305427) was used in flow cytometry on human samples . Nat Commun (2021) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; mouse; 1:100; fig 1k
BioLegend CD86 antibody (Biolegend, 305425) was used in flow cytometry on mouse samples at 1:100 (fig 1k). Nat Commun (2021) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; loading ...; fig 4d
BioLegend CD86 antibody (Biolegend, 374203) was used in flow cytometry on human samples (fig 4d). Oncogene (2021) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...
BioLegend CD86 antibody (BioLegend, 305418) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig s1c
BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on human samples (fig s1c). BMC Cancer (2020) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 2c, 4b
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig 2c, 4b). Rheumatology (Oxford) (2020) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; 1:100; loading ...; fig s20c
BioLegend CD86 antibody (Biolegend, 305432) was used in flow cytometry on human samples at 1:100 (fig s20c). Nat Commun (2020) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 4d
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig 4d). J Exp Med (2020) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig s2e
BioLegend CD86 antibody (Biolegend, 305402) was used in flow cytometry on human samples (fig s2e). Cell (2019) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 6h
BioLegend CD86 antibody (Biolegend, 305413) was used in flow cytometry on human samples (fig 6h). Oncoimmunology (2019) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD86 antibody (Biolegend, 305411) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD86 antibody (BioLegend, 305438) was used in flow cytometry on human samples (fig 2a). J Immunol (2019) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig 3a). Am J Respir Crit Care Med (2019) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD86 antibody (eBioscience, 305421) was used in flow cytometry on human samples (fig 3c). Cell (2019) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig 1b). BMC Immunol (2019) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig 1b). Front Immunol (2018) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 5b
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig 5b). J Immunol (2018) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig 2c). J Biol Chem (2018) ncbi
mouse monoclonal (IT2.2)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CD86 antibody (BioLegend, IT2.2) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 4c
BioLegend CD86 antibody (BioLegend, 305423) was used in flow cytometry on human samples (fig 4c). J Clin Invest (2017) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig s6a
In order to investigate the involvement of the TRIF pathway against the infection of Zika, Chikungunya, and Dengue viruses, BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig s6a). MBio (2017) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; 1:50; loading ...; fig s1d
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples at 1:50 (fig s1d). Nat Commun (2017) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; fig s4b
BioLegend CD86 antibody (BioLegend, IT 2.2) was used in flow cytometry on human samples (fig s4b). JCI Insight (2017) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; rhesus macaque; loading ...
In order to study the efficacy of nanoparticle adjuvants for inducing protective immunity against simian immunodeficiency virus, BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on rhesus macaque samples . J Virol (2017) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 1b
In order to investigate the roles of CD16+ monocytes in T-cell activation and B-cell responses in systemic lupus erythematosus, BioLegend CD86 antibody (Biolegend, 305431) was used in flow cytometry on human samples (fig 1b). Front Immunol (2016) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig s9a
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig s9a). PLoS Pathog (2016) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...
In order to determine which cells express CD83, BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 4a
In order to identify a role for HIV p17 in the development of leukemia/lymphoma, BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig 4a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD86 antibody (BioLegend, 305406) was used in flow cytometry on human samples (fig 2b). Oncogene (2017) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 7c
BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on human samples (fig 7c). J Biol Chem (2016) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; fig s6b
In order to test if AML patients treated decitabine have induced expression of cancer testis antigens, BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig s6b). Oncotarget (2016) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; fig 1
BioLegend CD86 antibody (BioLegend, 305405) was used in flow cytometry on human samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; fig 4
BioLegend CD86 antibody (Biolegend, 305420) was used in flow cytometry on human samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; fig 6
BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on human samples (fig 6). PLoS Pathog (2015) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; domestic horse; loading ...; fig 4
BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on domestic horse samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; fig 3
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on human samples (fig 3). J Exp Med (2015) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 9a
In order to explore a macrophage TLR9-BTK-calcineurin-NFAT signaling pathway involved in impair fungal immunity, BioLegend CD86 antibody (Biolegend, 305425) was used in flow cytometry on human samples (fig 9a). EMBO Mol Med (2015) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; fig 7
BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on human samples (fig 7). Toxicol Sci (2015) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
  • flow cytometry; mouse
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples and in flow cytometry on mouse samples . Hum Immunol (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; fig 1
BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; fig 4
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig 4). Infect Immun (2015) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on human samples . J Hepatol (2015) ncbi
mouse monoclonal (IT2.2)
  • blocking or activating experiments; human; 10 ug/ml
BioLegend CD86 antibody (BioLegend, IT2.2) was used in blocking or activating experiments on human samples at 10 ug/ml. Immunology (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
In order to examine various DC after flu vaccination, BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on human samples . Immunol Invest (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD86 antibody (Biolegend, IT2.2) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; mouse
BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 4d
In order to test if hip fracture and depressive symptoms had additive effects upon the aged immune system, BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig 4d). Exp Gerontol (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 2a
In order to assess how different concentrations of IFN-gamma affect dendritic cells, BioLegend CD86 antibody (BioLegend, IT2.2) was used in flow cytometry on human samples (fig 2a). J Leukoc Biol (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
BioLegend CD86 antibody (Biolegend, clone IT2.2) was used in flow cytometry on human samples . J Immunol Methods (2009) ncbi
Invitrogen
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig s4a
Invitrogen CD86 antibody (eBioscience, 62-0869-42) was used in flow cytometry on human samples (fig s4a). Immunity (2021) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 6h
Invitrogen CD86 antibody (Ebioscience, 12-0869-42) was used in flow cytometry on human samples (fig 6h). Oncoimmunology (2019) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig s3a
Invitrogen CD86 antibody (eBioscience, 12-0869-41) was used in flow cytometry on human samples (fig s3a). Cell (2019) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 2c
Invitrogen CD86 antibody (eBioscience, clone IT2.2) was used in flow cytometry on human samples (fig 2c). Cell Rep (2019) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 3e
Invitrogen CD86 antibody (eBioscience, IT2.2) was used in flow cytometry on human samples (fig 3e). Proc Natl Acad Sci U S A (2019) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, Invitrogen CD86 antibody (eBioscience, 12-0869-73) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig s4a
Invitrogen CD86 antibody (eBiosciences, IT2.2) was used in flow cytometry on human samples (fig s4a). J Exp Med (2017) ncbi
mouse monoclonal (BU63)
  • western blot; human; loading ...; fig 3d
In order to report the effects of long-term lipopolysaccharide exposure on monocytes, Invitrogen CD86 antibody (Thermo Fischer Scientific, MA1-10293) was used in western blot on human samples (fig 3d). Toxicol In Vitro (2017) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...
In order to use CRISPR/Cas9 editing to generate reagents to study the role of IRF8 in human hematopoiesis, Invitrogen CD86 antibody (eBioscience, IT2.2) was used in flow cytometry on human samples . Stem Cells (2017) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; loading ...; fig 2a
In order to measure CD80 and CD86 expression on CD14+HLA-DR+ monocytes from patients with Chagas disease, Invitrogen CD86 antibody (Invitrogen, MA1-10294) was used in flow cytometry on human samples (fig 2a). Rev Soc Bras Med Trop (2016) ncbi
mouse monoclonal (BU63)
  • western blot; human; loading ...
In order to investigate the role of tumor-associated-macrophages in breast cancer cell invasion and metastasis., Invitrogen CD86 antibody (Santacruz, MHCD8601) was used in western blot on human samples . Oncoimmunology (2016) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human; loading ...; fig 2b
In order to explore the role of miR-720 in M2 macrophage polarization, Invitrogen CD86 antibody (eBioscience, 53-0869-41) was used in flow cytometry on human samples (fig 2b). Biosci Rep (2016) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
In order to learn about stoichiometry of membrane proteins by single-molecule localization microscopy, Invitrogen CD86 antibody (eBioscience, IT2.2) was used in flow cytometry on human samples . Sci Rep (2015) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to study the role of melanoma cell surface-associated calreticulin in melphalan-induced antitumor immunity, Invitrogen CD86 antibody (BD, MHCD8605) was used in flow cytometry on human samples . Cancer Res (2015) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to study the role of autophagy in melanoma, Invitrogen CD86 antibody (Life Technologies, MHCD8605) was used in flow cytometry on human samples . Biochem Pharmacol (2015) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
Invitrogen CD86 antibody (eBioscience, IT2.2) was used in flow cytometry on human samples . PLoS Negl Trop Dis (2014) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
Invitrogen CD86 antibody (eBioscience, IT2.2) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 8
In order to explore the role of HIV in potentially modulating macrophage function, Invitrogen CD86 antibody (Invitrogen, BU63) was used in flow cytometry on human samples (fig 8). Retrovirology (2013) ncbi
mouse monoclonal (IT2.2)
  • flow cytometry; human
Invitrogen CD86 antibody (eBioscience, IT2.2) was used in flow cytometry on human samples . Clin Exp Immunol (2014) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to determine the role of HIV-1 Nef in dendritic cell-mediated viral transmission and HIV-1 infection, Invitrogen CD86 antibody (Caltag Laboratories, BU63) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; tbl 3
In order to examine the effects of age and gender on TLR9 expression on human DCs, Invitrogen CD86 antibody (Caltag, Bu63) was used in flow cytometry on human samples (tbl 3). Hum Immunol (2012) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 1
In order to test if follicular dendritic cells contribute to the antigen-presenting capability of B cells, Invitrogen CD86 antibody (BioSource, BU63) was used in flow cytometry on human samples (fig 1). Cell Immunol (2012) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; tbl 1
In order to discuss methods to generate human monocyte-derived DCs and assess their maturation, activation, and function, using interaction with the gram-negative bacterial pathogen Neisseria meningitidis as a model, Invitrogen CD86 antibody (Invitrogen, BU63) was used in flow cytometry on human samples (tbl 1). Methods Mol Biol (2012) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to investigate the role of type I IFN and tetherin in HIV-1 infection of dendritic cells, Invitrogen CD86 antibody (Invitrogen, BU63) was used in flow cytometry on human samples . Retrovirology (2011) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 1, 2, 3
In order to test if Th1- and Th2-like conditions alter antigen expression and function of plasmacytoid dendritic cells, Invitrogen CD86 antibody (Invitrogen, BU63) was used in flow cytometry on human samples (fig 1, 2, 3). Allergy (2011) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 5
In order to study the effect of natural occurring viral ssRNA on DC function, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (fig 5). J Immunol (2009) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 3
In order to test if chondrocytes attract lymphocytes and if cartilage chondrocytes from patients with ankylosing spondylitis stimulate T cells in an HLA-restricted manner, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (fig 3). Arthritis Rheum (2009) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 3
In order to identify and characterize a signal transduction cascade in monocytes that results in their differentiation into dendritic cells, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (fig 3). J Immunol (2008) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 3
In order to identify changes in peripheral B cell subsets in patients with systemic lupus erythematosus, Invitrogen CD86 antibody (Invitrogen, BU63) was used in flow cytometry on human samples (fig 3). Arthritis Rheum (2008) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; tbl 1
In order to characterize B cells in human tonsils, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (tbl 1). Blood (2007) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; tbl 2
  • immunocytochemistry; human; fig 2h
In order to compare X-L of Mac -1 with other neutrophil activators, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (tbl 2) and in immunocytochemistry on human samples (fig 2h). Immunology (2006) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to characterize dendritic cells in type 1 and type 2 diabetes, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples . Clin Immunol (2006) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 1
In order to show that human dendritic cells are an extrahepatic source of soluble complement proteins, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (fig 1). Inflamm Res (2006) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; tbl 1
In order to compare the immunogenic properties of human adipose tissue-derived stromal vascular fraction cells to adipose-derived stem cells, Invitrogen CD86 antibody (Caltag, MHCD8601) was used in flow cytometry on human samples (tbl 1). Stem Cells (2006) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to characterize gastric adenocarcinoma with and without residual neoplasic disease, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples . Cancer Immunol Immunother (2006) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 4
In order to show that human rhinoviruses alters the accessory molecule repertoire of dendritic cells, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (fig 4). J Immunol (2005) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 1
In order to show that oxidized phospholipid treatment interferes with dendritic cell maturation, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (fig 1). J Immunol (2005) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; 3.3 ug/ml
In order to develop a dendritic cell-dedicated microarray, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples at 3.3 ug/ml. J Leukoc Biol (2005) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to test if transfer of allogeneic material to T cells modifies human alloresponses, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples . Am J Transplant (2005) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; tbl 1
In order to study human cytomegalovirus-specific CD4+ and CD8+ T cells, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (tbl 1). Eur J Immunol (2005) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to discuss the creation of stable T-cell lines to study their impact in inflammatory bowel disease, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples . Scand J Gastroenterol (2004) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 1
In order to report that bacterial ghosts can deliver nucleic acid-encoded antigens, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (fig 1). J Immunother (2005) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 6
In order to investigate how neutrophils present antigen, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (fig 6). Immunology (2005) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 4
In order to elucidate how the monoclonal antibody, 11C9, reduces dendritic cell-induced T cell activation, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (fig 4). J Immunol (2004) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to report that OX40 ligand is selectively induced by IL-2, IL-12, or IL-15-activated human NK cells following stimulation through NKG2D, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples . J Immunol (2004) ncbi
mouse monoclonal (BU63)
  • flow cytometry; baboons
In order to describe the epidemiologic and clinical presentation of zinc toxicosis in baboons in captivity, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on baboons samples . J Med Primatol (2004) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to study T-cell lines from gastric cancer patients and healthy volunteers, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples . Cancer Immunol Immunother (2003) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to report that CD34(+) progenitor cell-derived Langerhans cells-type DCs exhibit a differentiation state-dependent susceptibility to CMV infection, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples . J Virol (2003) ncbi
mouse monoclonal (BU63)
  • ELISA; human; fig 6
In order to identify immunoregulatory molecules on dendritic cells, Invitrogen CD86 antibody (Caltag, BU63) was used in ELISA on human samples (fig 6). J Immunol (2003) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 1
In order to elucidate the importance of C domains in the functioning of CD80 and CD86, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (fig 1). Int Immunol (2003) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to study the ability of mononuclear cells from juvenile myelo-monocytic leukemia patients to act as antigen presenting cells, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples . Hematol J (2002) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to test if CD40L activates the antigen-presenting cell capacity of B cell precursor acute lymphoblastic leukemia cells, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples . Leukemia (2002) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to examine the ability of Leishmania species to prime DCs for CD40L-dependent IL-12p70 secretion, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples . Infect Immun (2002) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 3
In order to study the molecular and functional changes induced in T cells that interact with the endothelium, Invitrogen CD86 antibody (Caltag, Bu63) was used in flow cytometry on human samples (fig 3). J Immunol (2002) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human
In order to clone and study CD93, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples . J Leukoc Biol (2002) ncbi
mouse monoclonal (BU63)
  • flow cytometry; human; fig 5a
In order to characterize CD4(+)CD25(+) human T cells, Invitrogen CD86 antibody (Caltag, BU63) was used in flow cytometry on human samples (fig 5a). Blood (2001) ncbi
Abcam
mouse monoclonal (BU63)
  • flow cytometry; rat; loading ...; fig 1b
Abcam CD86 antibody (Abcam, ab213044) was used in flow cytometry on rat samples (fig 1b). Biosci Rep (2020) ncbi
Bio-Rad
mouse monoclonal (BU63)
  • flow cytometry; human; 1:200; fig 5
Bio-Rad CD86 antibody (AbD Serotec, MCA1118F) was used in flow cytometry on human samples at 1:200 (fig 5). Oncoimmunology (2016) ncbi
mouse monoclonal (BU63)
  • immunohistochemistry - frozen section; human; 1:400
  • flow cytometry; human; 1:50
Bio-Rad CD86 antibody (Serotec, MCA1118) was used in immunohistochemistry - frozen section on human samples at 1:400 and in flow cytometry on human samples at 1:50. J Neuroinflammation (2013) ncbi
Miltenyi Biotec
mouse monoclonal (FM95)
  • flow cytometry; human; loading ...; fig s2
Miltenyi Biotec CD86 antibody (Miltenyi Biotec, FM95) was used in flow cytometry on human samples (fig s2). Toxicol Appl Pharmacol (2018) ncbi
mouse monoclonal (FM95)
  • flow cytometry; human; 1:11; loading ...; fig s8d
Miltenyi Biotec CD86 antibody (Miltenyi Biotec, FM95) was used in flow cytometry on human samples at 1:11 (fig s8d). Nat Commun (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (BU63)
  • western blot; human
Santa Cruz Biotechnology CD86 antibody (Santa Cruz, sc-19617) was used in western blot on human samples . J Biomed Mater Res A (2015) ncbi
BD Biosciences
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig s1c, s1d
BD Biosciences CD86 antibody (BD Pharmingen, 560958) was used in flow cytometry on human samples (fig s1c, s1d). Arthritis Res Ther (2022) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig s2d
BD Biosciences CD86 antibody (BD, 560958) was used in flow cytometry on human samples (fig s2d). Nat Commun (2022) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig 1f
BD Biosciences CD86 antibody (BD Biosciences, 560957) was used in flow cytometry on human samples (fig 1f). Cell Res (2020) ncbi
mouse monoclonal (IT2.2)
  • mass cytometry; human; 500 ug/ml; loading ...; fig s11a
BD Biosciences CD86 antibody (BD, IT2.2) was used in mass cytometry on human samples at 500 ug/ml (fig s11a). Nature (2020) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; fig 5c
BD Biosciences CD86 antibody (BD, 560956) was used in flow cytometry on human samples (fig 5c). Cell Death Dis (2019) ncbi
mouse monoclonal (2331)
  • mass cytometry; human; loading ...; fig 2j
BD Biosciences CD86 antibody (BD Biosciences, 555655) was used in mass cytometry on human samples (fig 2j). Cell (2019) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig 4e
BD Biosciences CD86 antibody (BD, 2331) was used in flow cytometry on human samples (fig 4e). Nat Med (2019) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; 1:50; loading ...; fig s6a
BD Biosciences CD86 antibody (BD Bioscience, 555657) was used in flow cytometry on human samples at 1:50 (fig s6a). Nat Commun (2019) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD86 antibody (BD, 2331) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig s4a
BD Biosciences CD86 antibody (BD Biosciences, 2331 FUN-1) was used in flow cytometry on human samples (fig s4a). Cancer (2019) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; fig 8c
BD Biosciences CD86 antibody (BD Pharmingen, 2331) was used in flow cytometry on human samples (fig 8c). elife (2017) ncbi
mouse monoclonal (IT2.2)
  • mass cytometry; human; loading ...; fig 1j
In order to map the lineage of human dendritic cells, BD Biosciences CD86 antibody (BD Biosciences, IT2.2) was used in mass cytometry on human samples (fig 1j). Science (2017) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BD Biosciences CD86 antibody (BD, 2331) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; fig 1c
In order to elucidate the effects of pathogen recognition receptors on dendritic cell maturation, HIV infection, and on the quality of HIV-specific cytotoxic T-cell activation, BD Biosciences CD86 antibody (BD Pharmingen, 2331) was used in flow cytometry on human samples (fig 1c). Eur J Immunol (2017) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig s1a
In order to elucidate the impact of plasma membrane integrity on bacterial replication in different functional populations of human primary macrophages, BD Biosciences CD86 antibody (BD, 2331) was used in flow cytometry on human samples (fig s1a). J Cell Biol (2017) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences CD86 antibody (BD Biosciences, 2331 (FUN-1)) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig 2c
In order to assess the effects of sialic acid blockade on dendritic cells, BD Biosciences CD86 antibody (BD Bioscience, 2331) was used in flow cytometry on human samples (fig 2c). Immunol Cell Biol (2017) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig 7a
In order to compare the effect of CXCL4 and its variant CXCL4L1 on the differentiation of monocytes into macrophages and into immature monocyte-derived dendritic cells, BD Biosciences CD86 antibody (BD Biosciences, 2331) was used in flow cytometry on human samples (fig 7a). PLoS ONE (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD86 antibody (BD Biosciences, 2331 (FUN-1)) was used in flow cytometry on human samples (fig 1c). J Biol Chem (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig st1
BD Biosciences CD86 antibody (BD Biosciences, 555657) was used in flow cytometry on human samples (fig st1). PLoS ONE (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; fig 5
In order to investigate the impact of CD1c positive dendritic cells on immunogenic cell death, BD Biosciences CD86 antibody (BD PharMingen, 561128) was used in flow cytometry on human samples (fig 5). Oncoimmunology (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; fig 4
BD Biosciences CD86 antibody (BD Biosciences, 555657) was used in flow cytometry on human samples (fig 4). Oncoimmunology (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD86 antibody (BD Biosciences, 2331 FUN-1) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; 1:200; loading ...; fig 7h
In order to find that coagulation factor XII modulates immune responses, BD Biosciences CD86 antibody (BD Biosciences, 2331) was used in flow cytometry on human samples at 1:200 (fig 7h). Nat Commun (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD86 antibody (BD, 555658) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; fig st1
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BD Biosciences CD86 antibody (BD Biosciences, 2331) was used in flow cytometry on human samples (fig st1). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig 7c
BD Biosciences CD86 antibody (BD Bioscience, 2331) was used in flow cytometry on human samples (fig 7c). PLoS ONE (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD86 antibody (BD Pharmingen, 560958) was used in flow cytometry on human samples (fig 2a). Mol Med Rep (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...
In order to elucidate the role of TfR1 in adaptive immunity, BD Biosciences CD86 antibody (BD Biosciences, 2331) was used in flow cytometry on human samples . Nat Genet (2016) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CD86 antibody (BD Biosciences, 2331(Fun-1)) was used in flow cytometry on human samples (fig s3). Sci Transl Med (2015) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; fig 2
In order to characterize dendritic cell lipid content, function and phenotype due to mesothelioma tumor cell modulation, BD Biosciences CD86 antibody (BD Pharmingen, 2331 (FUN-1)) was used in flow cytometry on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (Pharmingen, 555660) was used in flow cytometry on human samples . Springerplus (2015) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; fig 3b
BD Biosciences CD86 antibody (BD Pharmingen, 2331) was used in flow cytometry on human samples (fig 3b). Front Immunol (2015) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; 1:200; loading ...; fig 2a
BD Biosciences CD86 antibody (BD Biosciences, 17-0247) was used in flow cytometry on human samples at 1:200 (fig 2a). Mol Med Rep (2015) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD Pharmingen, 562432) was used in flow cytometry on human samples . Alcohol (2015) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD Biosciences, 2331) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD, 2331) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; tbl 1
BD Biosciences CD86 antibody (BD Biosciences, 555658) was used in flow cytometry on human samples (tbl 1). Exp Ther Med (2015) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD, 2331) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD86 antibody (BD Biosciences, 555657) was used in flow cytometry on human samples (fig 1). Methods Mol Biol (2015) ncbi
mouse monoclonal (2331)
  • immunohistochemistry - paraffin section; human; 1:100
BD Biosciences CD86 antibody (BD Biosciences, 555657) was used in immunohistochemistry - paraffin section on human samples at 1:100. Mol Med Rep (2015) ncbi
mouse monoclonal (2331)
  • flow cytometry; human; loading ...; fig 5
In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., BD Biosciences CD86 antibody (BD, 2331) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD Biosciences, 2331) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (IT2.2)
  • immunocytochemistry; human
In order to study the role of dendritic cells in relation to T cells, BD Biosciences CD86 antibody (BD Biosciences, IT2.2) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD Biosciences, 2331) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD Biosciences, 233) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD Biosciences, 2331 (FUN-1)) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD Biosciences, 2331(FUN-1)) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD, 2331 (FUN-1)) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD Biosciences, 2331 (FUN-1)) was used in flow cytometry on human samples . Mol Immunol (2014) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
In order to discuss the use of PPR ligands as adjuvants and the use of interferon-gamma release assays as a diagnostic tool, BD Biosciences CD86 antibody (BD, 555657) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
BD Biosciences CD86 antibody (BD Biosciences, 555657) was used in flow cytometry on human samples . Invest Ophthalmol Vis Sci (2012) ncbi
mouse monoclonal (2331)
  • flow cytometry; human
In order to describe protocols for immunostaining and multiparameter flow cytometric analysis of major human antigen-presenting cells in peripheral blood, BD Biosciences CD86 antibody (BD, 555658) was used in flow cytometry on human samples . Nat Protoc (2010) ncbi
Articles Reviewed
  1. Yao Y, Cai X, Zhang M, Zhang X, Ren F, Zheng Y, et al. PSTPIP2 regulates synovial macrophages polarization and dynamics via ERβ in the joint microenvironment. Arthritis Res Ther. 2022;24:247 pubmed publisher
  2. Lei X, Lin H, Wang J, Ou Z, Ruan Y, Sadagopan A, et al. Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression. Nat Commun. 2022;13:3882 pubmed publisher
  3. Li M, Jiang H, Chen S, Ma Y. GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma. Bioengineered. 2022;13:11320-11341 pubmed publisher
  4. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  5. Rodriguez E, Boelaars K, Brown K, Eveline Li R, Kruijssen L, Bruijns S, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12:1270 pubmed publisher
  6. Arenas E, Martínez Sabadell A, Rius Ruiz I, Román Alonso M, Escorihuela M, Luque A, et al. Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation. Nat Commun. 2021;12:1237 pubmed publisher
  7. Fletcher R, Tong J, Risnik D, Leibowitz B, Wang Y, Concha Benavente F, et al. Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis. Oncogene. 2021;40:2035-2050 pubmed publisher
  8. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  9. Morrissey M, Byrne R, Nulty C, McCabe N, Lynam Lennon N, Butler C, et al. The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation. BMC Cancer. 2020;20:566 pubmed publisher
  10. Wu J, Song D, Li Z, Guo B, Xiao Y, Liu W, et al. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. Cell Res. 2020;30:794-809 pubmed publisher
  11. Kim J, Jeong J, Jung J, Jeon H, Lee S, Lim J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;: pubmed publisher
  12. Liang Y, Luo J, Yang N, Wang S, Ye M, Pan G. Activation of the IL-1β/KLF2/HSPH1 pathway promotes STAT3 phosphorylation in alveolar macrophages during LPS-induced acute lung injury. Biosci Rep. 2020;40: pubmed publisher
  13. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed publisher
  14. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher
  15. Chen Y, Gomes T, Hardman C, Vieira Braga F, Gutowska Owsiak D, Salimi M, et al. Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation. J Exp Med. 2020;217: pubmed publisher
  16. Li W, Zhang X, Wu F, Zhou Y, Bao Z, Li H, et al. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer. Cell Death Dis. 2019;10:918 pubmed publisher
  17. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed publisher
  18. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  19. Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C, et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7 pubmed publisher
  20. Gu C, Wang L, Zurawski S, Oh S. Signaling Cascade through DC-ASGPR Induces Transcriptionally Active CREB for IL-10 Induction and Immune Regulation. J Immunol. 2019;: pubmed publisher
  21. Ahmed R, Omidian Z, Giwa A, Cornwell B, Majety N, Bell D, et al. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen. Cell. 2019;177:1583-1599.e16 pubmed publisher
  22. Allden S, Ogger P, Ghai P, McErlean P, Hewitt R, Toshner R, et al. The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019;: pubmed publisher
  23. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  24. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed publisher
  25. Frank A, Ebersberger S, Fink A, Lampe S, Weigert A, Schmid T, et al. Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype. Nat Commun. 2019;10:1135 pubmed publisher
  26. Gentili M, Lahaye X, Nadalin F, Nader G, Puig Lombardi E, Hervé S, et al. The N-Terminal Domain of cGAS Determines Preferential Association with Centromeric DNA and Innate Immune Activation in the Nucleus. Cell Rep. 2019;26:2377-2393.e13 pubmed publisher
  27. Georgouli M, Herraiz C, Crosas Molist E, Fanshawe B, Maiques O, Perdrix A, et al. Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment. Cell. 2019;176:757-774.e23 pubmed publisher
  28. Tremblay McLean A, Coenraads S, Kiani Z, Dupuy F, Bernard N. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function. BMC Immunol. 2019;20:8 pubmed publisher
  29. Alam M, Yang D, Trivett A, Meyer T, Oppenheim J. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Front Immunol. 2018;9:2982 pubmed publisher
  30. Ha D, Tanaka A, Kibayashi T, Tanemura A, Sugiyama D, Wing J, et al. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody. Proc Natl Acad Sci U S A. 2019;116:609-618 pubmed publisher
  31. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
  32. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed publisher
  33. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
  34. Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed publisher
  35. Mussotter F, Potratz S, Budczies J, Luch A, Haase A. A multi-omics analysis reveals metabolic reprogramming in THP-1 cells upon treatment with the contact allergen DNCB. Toxicol Appl Pharmacol. 2018;340:21-29 pubmed publisher
  36. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed publisher
  37. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  38. Watanabe R, Shirai T, Namkoong H, Zhang H, Berry G, Wallis B, et al. Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest. 2017;127:2725-2738 pubmed publisher
  39. Castella B, Kopecka J, Sciancalepore P, Mandili G, Foglietta M, Mitro N, et al. The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells. Nat Commun. 2017;8:15663 pubmed publisher
  40. Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M, et al. Functionally diverse human T cells recognize non-microbial antigens presented by MR1. elife. 2017;6: pubmed publisher
  41. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed publisher
  42. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  43. Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed publisher
  44. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  45. Mytych J, Romerowicz Misielak M, Koziorowski M. Long-term culture with lipopolysaccharide induces dose-dependent cytostatic and cytotoxic effects in THP-1 monocytes. Toxicol In Vitro. 2017;42:1-9 pubmed publisher
  46. Cardinaud S, Urrutia A, Rouers A, Coulon P, Kervevan J, Richetta C, et al. Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells. Eur J Immunol. 2017;47:818-829 pubmed publisher
  47. Lerner T, Borel S, Greenwood D, Repnik U, Russell M, Herbst S, et al. Mycobacterium tuberculosis replicates within necrotic human macrophages. J Cell Biol. 2017;216:583-594 pubmed publisher
  48. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed publisher
  49. Martin Gayo E, Cronin J, Hickman T, Ouyang Z, Lindqvist M, Kolb K, et al. Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth. JCI Insight. 2017;2:e89574 pubmed publisher
  50. Sontag S, Förster M, Qin J, Wanek P, Mitzka S, Schüler H, et al. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells. Stem Cells. 2017;35:898-908 pubmed publisher
  51. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  52. Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed publisher
  53. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  54. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  55. Bull C, Collado Camps E, Kers Rebel E, Heise T, Søndergaard J, den Brok M, et al. Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation. Immunol Cell Biol. 2017;95:408-415 pubmed publisher
  56. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  57. Gouwy M, Ruytinx P, Radice E, Claudi F, Van Raemdonck K, Bonecchi R, et al. CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. PLoS ONE. 2016;11:e0166006 pubmed publisher
  58. Soares A, Neves P, Cavalcanti M, Marinho S, Oliveira W, Souza J, et al. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens. Rev Soc Bras Med Trop. 2016;49:632-636 pubmed publisher
  59. Carroll V, Lafferty M, Marchionni L, Bryant J, Gallo R, Garzino Demo A. Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice. Proc Natl Acad Sci U S A. 2016;113:13168-13173 pubmed
  60. Fatehchand K, McMichael E, Reader B, Fang H, Santhanam R, Gautam S, et al. Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells. J Biol Chem. 2016;291:25656-25666 pubmed
  61. Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS ONE. 2016;11:e0162209 pubmed publisher
  62. Di Blasio S, Wortel I, van Bladel D, de Vries L, Duiveman de Boer T, Worah K, et al. Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death. Oncoimmunology. 2016;5:e1192739 pubmed publisher
  63. Baghel K, Tewari B, Shrivastava R, Malik S, Lone M, Jain N, et al. Macrophages promote matrix protrusive and invasive function of breast cancer cells via MIP-1? dependent upregulation of MYO3A gene in breast cancer cells. Oncoimmunology. 2016;5:e1196299 pubmed publisher
  64. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
  65. Hirayama M, Tomita Y, Yuno A, Tsukamoto H, Senju S, Imamura Y, et al. An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs. Oncoimmunology. 2016;5:e1123368 pubmed publisher
  66. Zhong Y, Yi C. MicroRNA-720 suppresses M2 macrophage polarization by targeting GATA3. Biosci Rep. 2016;36: pubmed publisher
  67. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed publisher
  68. Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed publisher
  69. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  70. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  71. Hollmen M, Karaman S, Schwager S, Lisibach A, Christiansen A, Maksimow M, et al. G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer. Oncoimmunology. 2016;5:e1115177 pubmed
  72. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  73. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  74. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
  75. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Blagitko Dorfs N, et al. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. Oncotarget. 2016;7:12840-56 pubmed publisher
  76. Gupta S, Termini J, Issac B, Guirado E, Stone G. Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors. PLoS ONE. 2016;11:e0148929 pubmed publisher
  77. Wang H, Feng F, Wang X, Wang R, Wu Y, Zhu M, et al. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma. Mol Med Rep. 2016;13:1077-82 pubmed publisher
  78. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  79. Yamagishi M, Katano H, Hishima T, Shimoyama T, Ota Y, Nakano K, et al. Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma. Sci Rep. 2015;5:17868 pubmed publisher
  80. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed publisher
  81. McCausland M, Juchnowski S, Zidar D, Kuritzkes D, Andrade A, Sieg S, et al. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy. PLoS ONE. 2015;10:e0139474 pubmed publisher
  82. Fricke F, Beaudouin J, Eils R, Heilemann M. One, two or three? Probing the stoichiometry of membrane proteins by single-molecule localization microscopy. Sci Rep. 2015;5:14072 pubmed publisher
  83. Rancan C, Schirrmann L, Hüls C, Zeidler R, Moosmann A. Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells. PLoS Pathog. 2015;11:e1004906 pubmed publisher
  84. Meulenbroeks C, van der Lugt J, van der Meide N, Willemse T, Rutten V, Zaiss D. Allergen-Specific Cytokine Polarization Protects Shetland Ponies against Culicoides obsoletus-Induced Insect Bite Hypersensitivity. PLoS ONE. 2015;10:e0122090 pubmed publisher
  85. Gardner J, Mamotte C, Patel P, Yeoh T, Jackaman C, Nelson D. Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function. PLoS ONE. 2015;10:e0123563 pubmed publisher
  86. Donis Maturano L, Sánchez Torres L, Cerbulo Vázquez A, Chacón Salinas R, García Romo G, Orozco Uribe M, et al. Prolonged exposure to neutrophil extracellular traps can induce mitochondrial damage in macrophages and dendritic cells. Springerplus. 2015;4:161 pubmed publisher
  87. Koning N, Kessen S, van der Voorn J, Appelmelk B, Jeurink P, Knippels L, et al. Human Milk Blocks DC-SIGN-Pathogen Interaction via MUC1. Front Immunol. 2015;6:112 pubmed publisher
  88. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed publisher
  89. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed publisher
  90. Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240-58 pubmed publisher
  91. Sun Z, Zhang C, Zou X, Jiang G, Xu Z, Li W, et al. Special AT-rich sequence-binding protein-1 participates in the maintenance of breast cancer stem cells through regulation of the Notch signaling pathway and expression of Snail1 and Twist1. Mol Med Rep. 2015;11:3235-542 pubmed publisher
  92. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed publisher
  93. Phadnis Moghe A, Crawford R, Kaminski N. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6. Toxicol Sci. 2015;144:39-50 pubmed publisher
  94. Martin S, Dudek Perić A, Maes H, Garg A, Gabrysiak M, Demirsoy S, et al. Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells. Biochem Pharmacol. 2015;93:290-304 pubmed publisher
  95. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed publisher
  96. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  97. Cousens L, Najafian N, Martin W, De Groot A. Tregitope: Immunomodulation powerhouse. Hum Immunol. 2014;75:1139-46 pubmed publisher
  98. Wang H, Zhang L, Zhang S, Li Y. Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells. Exp Ther Med. 2015;9:120-124 pubmed
  99. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  100. Boltjes A, van Montfoort N, Biesta P, Op den Brouw M, Kwekkeboom J, van der Laan L, et al. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function. J Infect Dis. 2015;211:1268-78 pubmed publisher
  101. Brummelman J, Veerman R, Hamstra H, Deuss A, Schuijt T, Sloots A, et al. Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells. Infect Immun. 2015;83:227-38 pubmed publisher
  102. Woodham A, Raff A, Da Silva D, Kast W. Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro. Methods Mol Biol. 2015;1249:135-49 pubmed publisher
  103. Liao S, Ding T, Rao X, Sun D, Sun P, Wang Y, et al. Cigarette smoke affects dendritic cell maturation in the small airways of patients with chronic obstructive pulmonary disease. Mol Med Rep. 2015;11:219-25 pubmed publisher
  104. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed publisher
  105. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed publisher
  106. Škrnjug I, Guzmán C, Rueckert C, Ruecker C. Cyclic GMP-AMP displays mucosal adjuvant activity in mice. PLoS ONE. 2014;9:e110150 pubmed publisher
  107. Maney N, Reynolds G, Krippner Heidenreich A, Hilkens C. Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. J Immunol. 2014;193:4914-4923 pubmed publisher
  108. Spaan M, Kreefft K, de Graav G, Brouwer W, de Knegt R, ten Kate F, et al. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses. J Hepatol. 2015;62:303-10 pubmed publisher
  109. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed publisher
  110. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed publisher
  111. Preciado Llanes L, Wing J, Foster R, Carlring J, Lees A, Read R, et al. Contact dependent suppression of CD4 T cell activation and proliferation by B cells activated through IgD cross-linking. Immunology. 2014;: pubmed publisher
  112. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed publisher
  113. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  114. Royle C, Graham D, Sharma S, Fuchs D, Boasso A. HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs. J Immunol. 2014;193:3538-48 pubmed publisher
  115. Marinho C, Azeredo E, Torrentes Carvalho A, Marins Dos Santos A, Kubelka C, de Souza L, et al. Down-regulation of complement receptors on the surface of host monocyte even as in vitro complement pathway blocking interferes in dengue infection. PLoS ONE. 2014;9:e102014 pubmed publisher
  116. Koido S, Homma S, Okamoto M, Takakura K, Mori M, Yoshizaki S, et al. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer. Clin Cancer Res. 2014;20:4228-39 pubmed publisher
  117. McNally A, Anderson J. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties. J Biomed Mater Res A. 2015;103:1380-90 pubmed publisher
  118. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  119. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  120. Balan S, Ollion V, Colletti N, Chelbi R, Montanana Sanchis F, Liu H, et al. Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells. J Immunol. 2014;193:1622-35 pubmed publisher
  121. Kobie J, Treanor J, Ritchlin C. Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody. Immunol Invest. 2014;43:606-15 pubmed publisher
  122. Gupta M, Kolli D, Molteni C, Casola A, Garofalo R. Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells. PLoS ONE. 2014;9:e99227 pubmed publisher
  123. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  124. Moreno Fernandez M, Joedicke J, Chougnet C. Regulatory T Cells Diminish HIV Infection in Dendritic Cells - Conventional CD4(+) T Cell Clusters. Front Immunol. 2014;5:199 pubmed publisher
  125. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed publisher
  126. Søndergaard J, Vinner L, Brix S. Natural mannosylation of HIV-1 gp120 imposes no immunoregulatory effects in primary human plasmacytoid dendritic cells. Mol Immunol. 2014;59:180-7 pubmed publisher
  127. Duggal N, Beswetherick A, Upton J, Hampson P, Phillips A, Lord J. Depressive symptoms in hip fracture patients are associated with reduced monocyte superoxide production. Exp Gerontol. 2014;54:27-34 pubmed publisher
  128. Babu R, Brown A. A consensus surface activation marker signature is partially dependent on human immunodeficiency virus type 1 Nef expression within productively infected macrophages. Retrovirology. 2013;10:155 pubmed publisher
  129. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed publisher
  130. Svajger U, Obermajer N, Jeras M. IFN-?-rich environment programs dendritic cells toward silencing of cytotoxic immune responses. J Leukoc Biol. 2014;95:33-46 pubmed publisher
  131. Vogel D, Vereyken E, Glim J, Heijnen P, Moeton M, van der Valk P, et al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation. 2013;10:35 pubmed publisher
  132. Gaur R, Suhosk M, Banaei N. In vitro immunomodulation of a whole blood IFN-? release assay enhances T cell responses in subjects with latent tuberculosis infection. PLoS ONE. 2012;7:e48027 pubmed publisher
  133. Gillespie E, Raychaudhuri N, Papageorgiou K, Atkins S, Lu Y, Charara L, et al. Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-?B. Invest Ophthalmol Vis Sci. 2012;53:7746-53 pubmed publisher
  134. St Gelais C, Coleman C, Wang J, Wu L. HIV-1 Nef enhances dendritic cell-mediated viral transmission to CD4+ T cells and promotes T-cell activation. PLoS ONE. 2012;7:e34521 pubmed publisher
  135. Garbe K, Bratke K, Wagner S, Virchow J, Lommatzsch M. Plasmacytoid dendritic cells and their Toll-like receptor 9 expression selectively decrease with age. Hum Immunol. 2012;73:493-7 pubmed publisher
  136. Kim J, Kim Y, Jeoung D, Choe J. Human follicular dendritic cells promote the APC capability of B cells by enhancing CD86 expression levels. Cell Immunol. 2012;273:109-14 pubmed publisher
  137. Jones H, Klein N, Dixon G. Human dendritic cell culture and bacterial infection. Methods Mol Biol. 2012;799:217-35 pubmed publisher
  138. Coleman C, Spearman P, Wu L. Tetherin does not significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef. Retrovirology. 2011;8:26 pubmed publisher
  139. Bratke K, Klein C, Kuepper M, Lommatzsch M, Virchow J. Differential development of plasmacytoid dendritic cells in Th1- and Th2-like cytokine milieus. Allergy. 2011;66:386-95 pubmed publisher
  140. Fung E, Esposito L, Todd J, Wicker L. Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry. Nat Protoc. 2010;5:357-70 pubmed publisher
  141. Schrauf C, Kirchberger S, Majdic O, Seyerl M, Zlabinger G, Stuhlmeier K, et al. The ssRNA genome of human rhinovirus induces a type I IFN response but fails to induce maturation in human monocyte-derived dendritic cells. J Immunol. 2009;183:4440-8 pubmed publisher
  142. Kuhne M, Erben U, Schulze Tanzil G, Köhler D, Wu P, Richter F, et al. HLA-B27-restricted antigen presentation by human chondrocytes to CD8+ T cells: potential contribution to local immunopathologic processes in ankylosing spondylitis. Arthritis Rheum. 2009;60:1635-46 pubmed publisher
  143. Wang J, Kobie J, Zhang L, Cochran M, Mosmann T, Ritchlin C, et al. An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. J Immunol Methods. 2009;341:106-16 pubmed publisher
  144. Stephens T, Nikoopour E, Rider B, Leon Ponte M, Chau T, Mikolajczak S, et al. Dendritic cell differentiation induced by a self-peptide derived from apolipoprotein E. J Immunol. 2008;181:6859-71 pubmed
  145. Jacobi A, Reiter K, Mackay M, Aranow C, Hiepe F, Radbruch A, et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum. 2008;58:1762-73 pubmed publisher
  146. Kolar G, Mehta D, Pelayo R, Capra J. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood. 2007;109:2545-52 pubmed
  147. Sandilands G, McCrae J, Hill K, Perry M, Baxter D. Major histocompatibility complex class II (DR) antigen and costimulatory molecules on in vitro and in vivo activated human polymorphonuclear neutrophils. Immunology. 2006;119:562-71 pubmed
  148. Summers K, Marleau A, Mahon J, McManus R, Hramiak I, Singh B. Reduced IFN-alpha secretion by blood dendritic cells in human diabetes. Clin Immunol. 2006;121:81-9 pubmed
  149. Reis E, Barbuto J, Isaac L. Human monocyte-derived dendritic cells are a source of several complement proteins. Inflamm Res. 2006;55:179-84 pubmed
  150. McIntosh K, Zvonic S, Garrett S, Mitchell J, Floyd Z, Hammill L, et al. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells. 2006;24:1246-53 pubmed
  151. Lopez Santalla M, Valeri A, Perez Blas M, Aguilera Montilla N, Gutierrez A, Lasa I, et al. Expression of CD45 and proliferative response to CD3 as suitable classification markers of patients with gastric adenocarcinoma. Cancer Immunol Immunother. 2006;55:744-8 pubmed
  152. Kirchberger S, Majdic O, Steinberger P, Bluml S, Pfistershammer K, Zlabinger G, et al. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J Immunol. 2005;175:1145-52 pubmed
  153. Bluml S, Kirchberger S, Bochkov V, Kronke G, Stuhlmeier K, Majdic O, et al. Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J Immunol. 2005;175:501-8 pubmed
  154. McIlroy D, Tanguy Royer S, Le Meur N, Guisle I, Royer P, Léger J, et al. Profiling dendritic cell maturation with dedicated microarrays. J Leukoc Biol. 2005;78:794-803 pubmed
  155. Game D, Rogers N, Lechler R. Acquisition of HLA-DR and costimulatory molecules by T cells from allogeneic antigen presenting cells. Am J Transplant. 2005;5:1614-25 pubmed
  156. Lozza L, Lilleri D, Percivalle E, Fornara C, Comolli G, Revello M, et al. Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells. Eur J Immunol. 2005;35:1795-804 pubmed
  157. Aguilera Montilla N, Perez Blas M, Valeri A, Lopez Santalla M, Rodríguez Juan C, Mencia A, et al. Higher proliferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell lines. Scand J Gastroenterol. 2004;39:1236-42 pubmed
  158. Kudela P, Paukner S, Mayr U, Cholujova D, Schwarczova Z, Sedlak J, et al. Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells. J Immunother. 2005;28:136-43 pubmed
  159. Sandilands G, Ahmed Z, Perry N, Davison M, Lupton A, Young B. Cross-linking of neutrophil CD11b results in rapid cell surface expression of molecules required for antigen presentation and T-cell activation. Immunology. 2005;114:354-68 pubmed
  160. Pfistershammer K, Majdic O, Stockl J, Zlabinger G, Kirchberger S, Steinberger P, et al. CD63 as an activation-linked T cell costimulatory element. J Immunol. 2004;173:6000-8 pubmed
  161. Zingoni A, Sornasse T, Cocks B, Tanaka Y, Santoni A, Lanier L. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol. 2004;173:3716-24 pubmed
  162. Frost P, Hubbard G, Dammann M, Snider C, Moore C, Hodara V, et al. White monkey syndrome in infant baboons (Papio species). J Med Primatol. 2004;33:197-213 pubmed
  163. Valeri A, Perez Blas M, Gutierrez A, Lopez Santalla M, Aguilera N, Rodríguez Juan C, et al. Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma. Cancer Immunol Immunother. 2003;52:708-14 pubmed
  164. Hertel L, Lacaille V, Strobl H, Mellins E, Mocarski E. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol. 2003;77:7563-74 pubmed
  165. Selenko Gebauer N, Majdic O, Szekeres A, Höfler G, Guthann E, Korthauer U, et al. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J Immunol. 2003;170:3637-44 pubmed
  166. Vasu C, Wang A, Gorla S, Kaithamana S, Prabhakar B, Holterman M. CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties. Int Immunol. 2003;15:167-75 pubmed
  167. Longoni D, D Amico G, Gaipa G, Bernasconi S, Vulcano M, Onnis P, et al. Commitment of juvenile myelo-monocytic (JMML) leukemic cells to spontaneously differentiate into dendritic cells. Hematol J. 2002;3:302-10 pubmed
  168. Todisco E, Gaipa G, Biagi E, Bonamino M, Gramigna R, Introna M, et al. CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia. Leukemia. 2002;16:2046-54 pubmed
  169. McDowell M, Marovich M, Lira R, Braun M, Sacks D. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect Immun. 2002;70:3994-4001 pubmed
  170. Berg L, James M, Alvarez Iglesias M, Glennie S, Lechler R, Marelli Berg F. Functional consequences of noncognate interactions between CD4+ memory T lymphocytes and the endothelium. J Immunol. 2002;168:3227-34 pubmed
  171. Steinberger P, Szekeres A, Wille S, Stockl J, Selenko N, Prager E, et al. Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning. J Leukoc Biol. 2002;71:133-40 pubmed
  172. Ng W, Duggan P, Ponchel F, Matarese G, Lombardi G, Edwards A, et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood. 2001;98:2736-44 pubmed